Analysis of Hospital Pharmacists’ Interventions in a Covid -19 Isolation Centre of a Tertiary Hospital in Ghana

Download Article

DOI: 10.21522/TIJPH.2013.10.02.Art005

Authors : Charles N.K. Ofei-Palm, Priscilla Ekpale, Godwin Gulbi, Evelyn Pokuaa Gyekye, Magdalene Akanglah, Abena Ogyaa Safo, Yao Ahonon, Philip K. Amoo, Augustina Koduah, Daniel Ankrah


Coronavirus disease 2019 (Covid-19) is a global pandemic that was first identified in the city of Wuhan, China, and declared On January 30, 2020, by the World Health Organization (WHO) as a Public Health Emergency of International Concern. In Ghana, the Korle Bu Teaching Hospital became one of the designated sites for the management of Covid-19 patients, and the pharmacists were part of the task force. This study aims to analyze hospital pharmacists’ interventions in a Covid-19 isolation center and to identify the evidence that supports the effect of such interventions. This was a retrospective study carried out by collecting and collating the interventions and recommendations made by the hospital pharmacists who worked at the isolation center from May 2020 to August 2020 at the peak of the pandemic. A total of 145 pharmacists’ interventions (PIs) were captured from the medication reviews of 53 patients: resulting in an average PI rate of 3 interventions per patient. Women accounted for 58.5% (31/53) of positivity in the study. The mean (SD) for age was 47.1(17.9). Physicians’ acceptance rate of PIs for Covid-19-positive patients was 95.2% (138/145). The most prevalent type of PIs was discharge counseling; 32.4 % (47/145), followed by untreated indication 10.3% (15/145), drug /dose omission 9% (13/145), and drug shortage/refill 9% (13/145) respectively. This study highlights the clinical relevance of pharmacists’ interventions in the Covid-19 era and the importance of teamwork to prevent medication errors.

Keywords: Covid-19, Fevers Unit, Ghana, Korle bu Teaching Hospital, Medication errors, Pharmacists intervention, Prescription errors.


[1] World Health Organization (WHO). Covid 19 Public Health Emergency of International Concern (PHEIC). Global research and innovation forum: towards a research roadmap. 2020. Available from

[2] World Health Organization Coronavirus disease (Covid-19) outbreak situation. Available from: Accessed 30.06.21.

[3] Singhal T. A review of coronavirus disease-2019 (Covid-19) Indian J Pediatr. 2020; 87:281–286.

[4] Centers for Disease Control and Prevention Coronavirus disease 2019 (Covid-19). How to protect yourself and others Available from. Accessed 10.06.20

[5] Keers, R. N., Williams, S. D., Cooke, J., & Ashcroft, D. M. (2013). Prevalence and nature of medication administration errors in health care settings: a systematic review of direct observational evidence. The Annals of pharmacotherapy, 47(2), 237–256. Available from

[6] Visacri, M. B., Figueiredo, I. V., & Lima, T. M. (2021). Role of pharmacist during the Covid-19 pandemic: A scoping review. Research in social & administrative pharmacy: RSAP, 17(1), 1799–1806.

[7] Alzahrani, Abdulhakim & Alwhaibi, Monira & Asiri, Yousif & Kamal, Khalid & Alhawassi, Tariq. (2020). Description of Pharmacists’ Reported Interventions to Prevent Prescribing Errors among in Hospital Inpatients: A Cross-Sectional Retrospective Study. 10.21203/

[8] Danelich, IM, Thomson, L, Alberto, J, (2021) Adaptation of clinical pharmacy services to meet patient care needs during the Covid-19 pandemic. J Am Coll Clin Pharm. 4: 364– 371.

[9] Global contributions of pharmacists during the Covid-19 pandemic.

[10] Saad Ahmed Sami, Kay Shain Marma, Agnila Chakraborty, Tandra Singha, Ahmed Rakib, Md. Giash Uddin, Mohammed Kamrul Hossain, S. M. Naim Uddin, (2021) A comprehensive review on global contributions and recognition of pharmacy professionals amidst Covid-19 pandemic: moving from present to future, Future Journal of Pharmaceutical Sciences, 10.1186/s43094-021-00273-9, 7, 1.

[11] Cheong, MWL. (2020) “To be or not to be in the ward”: The impact of Covid-19 on the role of hospital-based clinical pharmacists—A qualitative study. J Am Coll Clin Pharm.; 3: 1458– 1463.

[12] Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the Covid-19 epidemic. RSAP. (2021) 17:1978–83. Doi: 10.1016/j.sapharm.2020.04.001.

[13] Kaitlyn E. Watson, Theresa J. Schindel, Marina E. Barsoum, Janice Y. Kung, (2021) Covid the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists’ Roles and Services as a Response to the Covid-19 Pandemic, Pharmacy, 10.3390/pharmacy9020099, 9, 2, (99).

[14] Jeff Aston, Inderjit Singh, Caroline Cheng, Aisling Considine, (2021). Hospital pharmacy response to Covid-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy, European Journal of Hospital Pharmacy, 10.1136/ejhpharm-2020-002626, (ejhpharm-2020-002626).

[15] Curtis D Collins, Nina West, David M Sudekum, Jason P Hecht, (2020) Perspectives from the frontline: A pharmacy department’s response to the Covid-19 pandemic, American Journal of Health-System Pharmacy, 10.1093/ajhp/zxaa176.

[16] International Pharmaceutical Federation. Covid-19: Guidelines for Pharmacists and the Pharmacy Workforce. 2020. English pdf [Accessed 5 April 2020].

[17] APhA. American Pharmacists Association. American Pharmacists Association; Washington: APhA: 2020. Pharmacist Guide to Coronavirus. Available from Accessed date: 18.06.20.

[18] Society of Hospital Pharmacists of Australia. Hospital pharmacists in a new national task force to support clinicians providing Covid-19 care.

[19] Liao, Y., Ma, C., Lau, A. H., & Zhong, M. (2020). Role of pharmacists during the Covid-19 pandemic in China - Shanghai Experiences. Journal of the American College of Clinical Pharmacy: JACCP,10.1002/jac5.1288. Advance online publication.

[20] Khatiwada AP, Shrestha S. (2020) Pharmacy Patronage: Identifying the Roles of Nepalese Pharmacists in Tacking Covid-19, J Pure Appl Microbiol.; 14(suppl 1):937-943. Doi: 10.22207/JPAM.14.SPL1.31.

[21]    Falconer, N., Monaghan, C., & Snoswell, C. L. (2021). The pharmacist informatician: providing an innovative model of care during the Covid-19 crisis. The International Journal of pharmacy practice, 29(2), 152–156.

[22]        Kashif Hussain, Gul Ambreen, Mehreen Muzammil, Syed Shamim Raza, Umer Ali, (2020). Pharmacy services during Covid-19 pandemic: experience from a tertiary care teaching hospital in Pakistan, Journal of Pharmaceutical Policy and Practice, 10.1186/s40545-020-00277-5, 13, 1.

[23] Ashley Fan, Megan Kamath, Comment on Gross and MacDougall. (2020). “Roles of the clinical pharmacist during the Covid19 pandemic”, Jaccp: Journal of the American College of Clinical Pharmacy, 10.1002/jac5.1252, 3, 4, (828-828).

[24] Perez, M., Masse, M., Deldicque, A., Beuscart, J. B., De Groote, P., Desbordes, J., Fry, S., Musy, E., Odou, P., Puisieux, F., Lambert, M., Scherpereel, A., & Décaudin, B. (2021). Analysis of clinical pharmacist interventions in the Covid-19 units of a French university hospital. European journal of hospital pharmacy: science and practice, ejhpharm-2020-002542. Advance online publication.

[25] Hua X., Gu M., Zeng F. (2020). Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. J Am Pharm Assoc JAPhA; 60:431–438.

[26] Alwhaibi, A., Alrwaished, A., Binobydaan, S. M., Alawwad, S., Wajid, S., Bablghaith, S., Alghadeer, S., & Al Arifi, M. N. (2021). Role of pharmacist during Covid-19 pandemic: A retrospective study focused on critically ill Covid-19 patients. Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society, 29(9), 1050–1055.

[27] Louiselle, K., Elson, E. C., Oschman, A., & Duehlmeyer, S. (2020). Impact of Covid-19 pandemic on pharmacy learners and preceptors. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists, 77(14), 1097–1099.

[28] Wang, D, Liu, Y, Zeng, F (2021). Evaluation of the role and usefulness of clinical pharmacists at the Fangcang Hospital during Covid-19 outbreak. Int J Clin Pract, 75(4), 4271-4275.

[29] Pruc, M., Golik, D., Szarpak, L., Adam, I., & Smereka, J. (2021). Covid-19 in healthcare workers. The American journal of emergency medicine, 39, 236.

[30] A.J. Keeley, C. Evans, H. Colton, et al.Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom. Euro Surveill, 25 (14) (2020), p.2000433, 10.2807/1560-7917.ES.2020.25.14.2000433.

[31] Tostmann, J. Bradley, T. Bousema, et al.Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, The Netherlands, March 2020.Euro Surveill, 25 (16) (2020), p. 2000508.

[32] Vargese SS, Dev SS, Soman A S, Kurian N, Varghese V A, Mathew E. Exposure risk and Covid-19 infection among frontline health-care workers: A single tertiary care centre experience. Clin Epidemiol Glob Health. 2022; 13:100933. Doi:10.1016/j.cegh.2021.100933.

[33] Sabetian, G., Moghadami, M., Hashemizadeh Fard Haghighi, L. et al. Covid-19 infection among healthcare workers: a cross-sectional study in southwest Iran. Virol J 18, 58 (2021).

[34] Wei-jie Guan, Wen-hua Liang, Yi Zhao, Heng-rui Liang, et al Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. European Respiratory Journal 2020 55: 2000547; Doi: 10.1183/13993003.00547-2020.

[35] Huang C, Wang Y, Li X, et al. Clinical features of patients with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. doi:10.1016/S0140-6736(20)30183-5.

[36] Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case studies. BMJ 2020; 368: m606. doi:10.1136/bmj.m606.

[37] Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., the Northwell Covid-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., Cohen, S. L., Cookingham, J., Coppa, K., Diefenbach, M. A., Dominello, A. J., Duer-Hefele, J., Falzon, L., Gitlin, J., Hajizadeh, N., Harvin, T. G., Zanos, T. P. (2020). Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized with Covid-19 in the New York City Area. JAMA, 323(20), 2052–2059.

[38] Perez, M., Masse, M., Deldicque, A., Beuscart, J. B., De Groote, P., Desbordes, J., Fry, S., Musy, E., Odou, P., Puisieux, F., Lambert, M., Scherpereel, A., & Décaudin, B. (2021). Analysis of clinical pharmacist interventions in the Covid-19 units of a French university hospital. European journal of hospital pharmacy: science and practice, ejhpharm-2020-002542. Advance online publication.

[39] Zaal, R. J., den Haak, E. W., Andrinopoulou, E. R., van Gelder, T., Vulto, A. G., & van den Bemt, P. (2020). Physicians’ acceptance of pharmacists’ interventions in daily hospital practice. International journal of clinical pharmacy, 42(1),

[40] Faqeer, N., Mustafa, N., Abd Al-Jalil, N., & Qur’an, T. (2021). Impact of clinical pharmacists in an inpatient medical oncology service: A prospective study at a comprehensive cancer center in Jordan. Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners, 27(4), 897–901.

[41] Recovery and rehabilitation for patients following the pandemic. The Faculty of Intensive Care Medicine. 2020. (accessed December 2021).

[42] Delpeuch, A., Leveque, D., Gourieux, B., & Herbrecht, R. (2015). Impact of clinical pharmacy services in a hematology/oncology inpatient setting. Anticancer research, 35(1), 457–460.

[43] Wang, R., Kong, L., Xu, Q., Yang, P., Wang, X., Chen, N., Li, L., Jiang, S., & Lu, X. (2021). On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with Covid-19: A retrospective, observational study. Research in social & administrative pharmacy: RSAP, 17(1), 1853–1858.